Abstract:Abstract Background Interleukin-33 (IL-33) plays a pivotal role in regulating innate immune response and metabolic homeostasis. However, whether its circulating level is correlated with obesity and metabolic disorders in humans remains largely unknown. We aimed to address this gap by determining IL-33 serum level and its downstream type 2 inflammatory cytokines interleukin-5 (IL-5) and interleukin-13 (IL-13) in overweight/obese population, and analyzing the specific associations between IL-33 and obesity metabolic phenotypes. Methods 217 subjects were enrolled and divided into three groups: healthy control (HC) subjects, metabolically healthy overweight/obese (MHOO) subjects and metabolically unhealthy overweight/obese (MUOO) subjects. Circulating levels of IL-33, IL-5 and IL-13 were measured using ELISA analyses. Multivariate regression analyses were further performed to determine the independent association between IL-33 and obesity metabolic phenotypes. Results Circulating levels of IL-33 were significantly elevated in subjects of MUOO group compared with HC group and MHOO group, while no significant difference was observed between the latter two groups in IL-33 levels. Consistent with this, serum levels of IL-5/13 were higher in the MUOO group compared with HC and MHOO groups. After adjusted for all confounders, MUOO phenotype was significantly associated with increased IL-33 serum levels (OR = 1.70; 95% CI 1.09–2.64; p = 0.019). With the MHOO group as the reference population, higher circulating level of IL-33 was also positively associated with MUOO phenotype after adjusting for confounders (OR = 1.50; 95% CI 1.20–1.88; p = 2.91E−4). However, there was no significant association between MHOO phenotype and IL-33 levels ( p = 0.942). Trend analysis further confirmed the positive correlation between MUOO phenotype and IL-33 level ( p for trend = 0.019). Additionally, IL-33 was significantly and positively correlated with diastolic blood pressure (DBP), total cholesterol (TC), alanine aminotransferase (ALT), aspartate aminotransferase (AST), white blood cell (WBC), neutrophil and IL-5 only in MUOO group, while inversely correlated with high density lipoprotein cholesterol (HDL-C) in MHOO subjects. Conclusion Circulating levels of IL-33 were significantly elevated in overweight/obese Chinese adults with metabolic disorders. Increased levels of IL-33 were positively associated with metabolically unhealthy overweight/obese phenotype and several metabolic syndrome risk factors.

Interleukin-27 is Positively Correlated with Obesity and a Decrease in Insulin Resistance after Weight Loss

Correlation Between Interleukin-1 and the Obesity of Polycystic Ovary Syndrome

Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease

Circulating interleukin-33 levels in obesity and type 2 diabetes: A systematic review and meta-analysis

Interleukin-27 signaling resists obesity by promoting the accumulation of Treg cells in visceral adipose tissue

IL-27 signalling promotes adipocyte thermogenesis and energy expenditure

Circulating levels of IL-33 are elevated by obesity and positively correlated with metabolic disorders in Chinese adults

Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation

Interleukin-15 are associated with insulin resistance in postmenopausal women with metabolic syndrome

Increased Interleukin-32 Levels in Obesity Promote Adipose Tissue Inflammation and Extracellular Matrix Remodeling: Effect of Weight Loss

Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?

Preventing high-fat diet-induced obesity and related metabolic disorders by hydrodynamic transfer of Il-27 gene

Beneficial Metabolic Activities of Inflammatory Cytokine Interleukin 15 in Obesity and Type 2 Diabetes

Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro

Interleukin-18 Is a Potential Biomarker Linking Dietary Fatty Acid Quality and Insulin Resistance: Results from a Cross-Sectional Study in Northern Italy

The Roles of IL-6, IL-10, and IL-1RA in Obesity and Insulin Resistance in African-Americans.

Linking adipose tissue eosinophils, IL-4, and leptin in human obesity and insulin resistance

Modulation of the IL-33/IL-13 Axis in Obesity by IL-13Rα2

Effects of IL-33 on 3T3-L1 cells and obese mice models induced by a high-fat diet

Interleukin-4 Improves Metabolic Abnormalities in Leptin-Deficient and High-Fat Diet Mice

Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance